MYC acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferase.
about
MYC, Metabolism, and CancerA Myc-driven self-reinforcing regulatory network maintains mouse embryonic stem cell identity.EZH2 in Bladder Cancer, a Promising Therapeutic TargetMYC association with cancer risk and a new model of MYC-mediated repression.Overexpression of MYC and EZH2 cooperates to epigenetically silence MST1 expression.MYC cofactors: molecular switches controlling diverse biological outcomes.EZH2 in normal and malignant hematopoiesis.Methyl jasmonate sensitizes human bladder cancer cells to gambogic acid-induced apoptosis through down-regulation of EZH2 expression by miR-101.Taming of the beast: shaping Myc-dependent amplificationA Transition Zone Showing Highly Discontinuous or Alternating Levels of Stem Cell and Proliferation Markers Characterizes the Development of PTEN-Haploinsufficient Colorectal Cancer.Partial PTEN deletion is linked to poor prognosis in breast cancerMyc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells.Amplitude modulation of androgen signaling by c-MYC.Cellular MYCro economics: Balancing MYC function with MYC expression.Roles for MYC in the establishment and maintenance of pluripotency.An overview of MYC and its interactome.Polycomb group proteins and MYC: the cancer connection.EBV-negative aggressive NK-cell leukemia/lymphoma: a clinical and pathological study from a single institution.Muscle-specific expression of the RNA-binding protein Staufen1 induces progressive skeletal muscle atrophy via regulation of phosphatase tensin homolog.Targeting Enhancer of Zeste Homolog 2 as a promising strategy for cancer treatmentThe role of the polycomb repressive complex pathway in T and NK cell lymphoma: biological and prognostic implications.HDAC8 Prevents Anthrax Lethal Toxin-induced Cell Cycle Arrest through Silencing PTEN in Human Monocytic THP-1 Cells.Integrative analysis of RNA polymerase II and transcriptional dynamics upon MYC activation.c-Myc deregulation induces mRNA capping enzyme dependency.Let-7d increases ovarian cancer cell sensitivity to a genistein analog by targeting c-Myc.The EZH2 inhibitor GSK343 suppresses cancer stem-like phenotypes and reverses mesenchymal transition in glioma cells.C-MYC and BCL-2 mediate YAP-regulated tumorigenesis in OSCC.Regulation of Cellular Senescence by Polycomb Chromatin Modifiers through Distinct DNA Damage- and Histone Methylation-Dependent Pathways.PIM Kinases and Their Relevance to the PI3K/AKT/mTOR Pathway in the Regulation of Ovarian Cancer.Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma.Regulation and Function of the MYC Oncogene
P2860
Q26783555-B4F9F723-1B00-4B28-A22F-BD0C1A6F9321Q27343738-EF0B34B2-DDC2-4AD3-BC52-AA9CFE442369Q28082054-C916CE2F-F4F2-457B-9019-E58551E1F034Q33790662-7EC145FC-D98E-4407-A21F-E1B0F83C4396Q34000446-0A5E78C6-2D50-401C-A6EF-AFA7B876F17AQ34083178-4F807780-0EC2-492A-81FE-870772FBBA11Q34375614-E32E4DB6-3EAA-4DE5-A7D8-585CF3025BC1Q35086746-8AAEC3A8-62FB-45C3-95EE-775EE084012DQ35235723-E0C12DFA-30F8-414B-8540-AC085BC29F3DQ35670782-921184E6-111C-414A-A723-AB27D3A1A873Q35870069-22103291-A5A0-4945-B43E-6369F46394A0Q36275660-275F6968-966B-4C03-98A0-AB2626D98CE5Q36804105-73E9EB65-4D20-4A9B-9EBC-60B6D36DA919Q37256438-785E0EF4-6B01-4BB4-B49A-727DE09219CBQ37340352-AE49AC72-5CE6-435F-A788-1BA1D04C8EC1Q37406278-079F218C-2CBE-4664-BE6E-DA784D327654Q38125132-0E22F5CC-ABA7-4A90-9656-D86B630E25C9Q38761793-D8F72886-C64E-4DF6-882E-EEA13713A502Q38860146-2148BFC6-DFF1-4DED-A54A-2739BB1C7C5FQ40014635-01BCE204-2DD1-49CF-8914-FDD5FB218EE0Q41017260-241EF57A-D973-4752-B72B-B666A1172659Q41961377-E4119E32-AD12-413B-88AD-DBD0BE19F065Q42275753-886D8DD4-7145-417E-967F-7EBFB4A977F4Q42316813-6EA48910-6DAE-4A14-A46F-951BD97911C5Q44637964-66219ABE-7733-44DD-8214-87C554BCBCFCQ47150055-CE8CF301-7789-49CE-BB68-0BC352C1BA26Q49753044-37D2722C-1948-4A4B-97BB-360C1489A243Q51733364-A41ED3CA-086D-4D36-85D5-0979306C227AQ54984581-A04F03A7-9979-43F3-9939-3EF362822E6AQ55068347-CC89E885-352B-4A55-A5D0-F16EDFFC2742Q58327201-318AE5D3-0C92-41B9-BD24-6658C117CE77
P2860
MYC acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferase.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
MYC acts via the PTEN tumor su ...... of the Ezh2 methyltransferase.
@ast
MYC acts via the PTEN tumor su ...... of the Ezh2 methyltransferase.
@en
type
label
MYC acts via the PTEN tumor su ...... of the Ezh2 methyltransferase.
@ast
MYC acts via the PTEN tumor su ...... of the Ezh2 methyltransferase.
@en
prefLabel
MYC acts via the PTEN tumor su ...... of the Ezh2 methyltransferase.
@ast
MYC acts via the PTEN tumor su ...... of the Ezh2 methyltransferase.
@en
P2860
P1433
P1476
MYC acts via the PTEN tumor su ...... of the Ezh2 methyltransferase.
@en
P2093
Mandeep Kaur
Michael D Cole
P2860
P304
P356
10.1158/0008-5472.CAN-12-2522
P407
P577
2012-11-07T00:00:00Z